NCT05119582View on ClinicalTrials.gov

HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 13, 2022

Primary Completion Date

January 17, 2024

Study Completion Date

January 17, 2024

Conditions
Cutaneous Neurofibroma
Interventions
DEVICE

TOOsonix System ONE-M

Selected neurofibromas will be treated by high intensity focused ultrasound. Untreated fibromas will be used for controls.

Trial Locations (2)

2400

Bispebjerg Hospital, Copenhagen

41318

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

lead

Joergen Serup

OTHER